DYT1 (IMAGE) Duke University Caption As researchers hunt for new treatments for a rare movement disorder called dystonia, they are able to conduct drug screening tests by pushing the molecular culprit, the DYT1 protein (shown in green), to the wrong spot within cells. Credit Zac Caffall, Duke University Usage Restrictions None License Licensed content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.